Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 155Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Leukemia, Myelomonocytic, Acute 31Leukemia, Monocytic, Acute 31Leukemia, Erythroblastic, Acute 27Leukemia, Megakaryoblastic, Acute 25Congenital Abnormalities 23Myelodysplastic Syndromes 17Leukemia, Biphenotypic, Acute 14Burkitt Lymphoma 13Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Myeloproliferative Disorders 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Eosinophilic, Acute 8Leukemia, Basophilic, Acute 8Neoplasm, Residual 7Leukemia, Promyelocytic, Acute 7Leukemia, Myelomonocytic, Chronic 7Recurrence 6Hematologic Neoplasms 4Thrombocytopenia 3Neutropenia 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Down Syndrome 3Sarcoma, Myeloid 2Philadelphia Chromosome 2Neoplasm Metastasis 2

Interventions

Cytarabine 2venetoclax 1pembrolizumab 1obinutuzumab 1neratinib 1idelalisib 1ibrutinib 1gilteritinib 1Surveys and Questionnaires 1Positron Emission Tomography Computed Tomography 1Mitoxantrone 1Interleukin-15 1Gemtuzumab 1Daunorubicin 1CPX-351 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Daunorubicin × Other hematologic neoplasm × Clear all
NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Jazz Pharmaceuticals

Phase 2 Completed
126 enrolled 12 charts
Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡